Otsuka Pharmaceutical Co. Ltd. is targeting a U.S. rollout beginning as soon as this year for Abilify MyCite – a…...
Please subscribe to read the full story.
Otsuka Pharmaceutical
Tokushima, Tsukuba Universities Use Genome Editing to Create Tomato Without Pollination
A joint university research group has used genome editing technology to create tomatoes that can form without pollination. Led by…...
Please subscribe to read the full story.
Otsuka Pharmaceutical to Acquire Neurovance, Expand CNS Sector Engagement
Otsuka Pharmaceutical Co. Ltd. on March 3 announced that it will acquire U.S.-based bioventure Neurovance Inc., which is developing a treatment…...
Please subscribe to read the full story.
